Not classified as an open-market trade.
Loading…
Planned for Oct 5, 2026 · Notice filed Oct 5, 2026
A top manager at Charles River Laboratories told the SEC about a plan to sell $309K of Charles River Laboratories shares around Oct 5, 2026. The shares came from pay, which is the usual reason to sell.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
None found in footnotes
Only flagged when a footnote says so; never inferred
Not classified as an open-market trade.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.